Chee Fu Yung

Chee Fu Yung

Auto-generated profile, based on publicly available information

Chee Fu Yung

Infectious Diseases Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
CYChee Fu Yung
Chee Fu Yung
KKKai-Qian Kam
Kai-Qian Kam
KNKaren Donceras Nadua
Karen Donceras Nadua
CCChia Yin Chong
Chia Yin Chong
NTNatalie Woon Hui Tan
Natalie Woon Hui Tan
KNKee Chong Ng
Kee Chong Ng
Transmission risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools is unknown. Our investigations, especially in preschools, could not detect SARS-CoV-2 transmission despite screening of symptomatic and asymptomatic children. The data suggest that children are not the primary drivers of SARS-CoV-2 transmission in schools and could help inform exit strategies for lifting of lockdowns.

5 July 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
VOVittoria Offeddu
Vittoria Offeddu
CTClarence C. Tam
Clarence C. Tam
TYTze Tein Yong
Tze Tein Yong
LTLAY KOK TAN
LAY KOK TAN
KTKoh Cheng Thoon
Koh Cheng Thoon
CYChee Fu Yung
Chee Fu Yung
Pregnant women are at increased risk of influenza-related complications. The World Health Organisation recommends influenza vaccination to this high-risk population as highest priority. However, achieving high influenza vaccine coverage among pregnant women remains challenging. We conducted a cross-sectional survey to estimate the coverage and determinants of influenza vaccination among pregnant women in Singapore. Between September and November 2017, pregnant women aged ≥21 years were recruited at two public hospitals in Singapore. Participants completed an anonymous, self-administered online questionnaire assessing participants’ influenza vaccination uptake, knowledge of and attitudes towards influenza and the influenza vaccine, vaccination history, willingness to pay for the influenza vaccine, and external cues to vaccination. We estimated vaccine coverage and used multivariable Poisson models to identify factors associated with vaccine uptake. Response rate was 61% (500/814). Only 49 women (9.8, 95% Confidence Interval (CI): 7.3–12.7%) reported receiving the vaccine during their current pregnancy. A few misconceptions were identified among participants, such as the belief that influenza can be treated with antibiotics. The most frequent reason for not being vaccinated was lack of recommendation. Women who were personally advised to get vaccinated against influenza during pregnancy were 7 times more likely to be vaccinated (prevalence ratio (PR) = 7.11; 95% CI: 3.92–12.90). However, only 12% of women were personally advised to get vaccinated. Other factors associated with vaccine uptake were vaccination during a previous pregnancy (PR = 2.51; 95% CI: 1.54–4.11), having insurance to cover the cost of the vaccine (PR = 2.32; 95% CI: 1.43–3.76), and higher vaccine confidence (PR = 1.62; 95% CI: 1.30–2.01). Influenza vaccination uptake among pregnant women in Singapore is low. There is considerable scope for improving vaccination coverage in this high-risk population through vaccination recommendations from healthcare professionals, and public communication targeting common misconceptions about influenza and influenza vaccines.

1 April 2018 in Vaccine
Verified
Journal Article
Open access
NSNeisha Sundaram
Neisha Sundaram
KDKathryn Duckett
Kathryn Duckett
CYChee Fu Yung
Chee Fu Yung
KTKoh Cheng Thoon
Koh Cheng Thoon
SSSucitro Sidharta
Sucitro Sidharta
JYJoanne Su Yin Yoong
Joanne Su Yin Yoong
Influenza vaccine acceptance among healthcare workers (HCWs) is a worldwide problem, but relatively little research has focussed on Asia, including Singapore. Despite widespread access and recommendations from public health authorities, influenza vaccine uptake remains suboptimal among HCWs. Our qualitative study used focus group discussions to identify and explain factors limiting influenza vaccine acceptance among HCWs in Singapore. A total of 73 doctors, nurses, allied health and ancillary staff across three public hospitals were included. Challenges identified include a fear of contracting influenza from vaccination exacerbated by negative anecdotes regarding vaccine safety and efficacy, distrust of published efficacy data, uncertainty regarding relevance of existing data for Singapore, reluctance to introduce chemicals or overmedicate, pain from injection, low risk attributed to influenza and limited awareness of influenza transmission with a preference for alternatives in patient protection. Differences in attitudes were observed across vocational groups. Lack of overt promotion by hospital leadership in some institutions, perceived vaccine hesitancy among doctors, access, and work culture that implicitly encourages working through illness were further barriers. Our findings highlight a combination of misperceptions about influenza vaccination and cognitive biases at the individual level, and challenges at the institutional level limiting uptake. Findings indicate an urgent need to provide targeted education and communication. Rather than providing more data, we recommend a widely-disseminated, locally-compiled synthesis addressing specific concerns of hesitant HCWs. Tailoring interventions to specific vocational groups should be considered. Institutional norms and culture may have a powerful influence in setting default behaviours: more effort is needed in improving influenza vaccine promotion and priority at some institutions, integrating vaccine-related communication with other infection control communication and addressing influenza vaccine hesitancy among doctors as a priority. Finally, further study of strategies to address cognitive biases affecting influenza vaccine acceptance in Singapore is desirable.

28 May 2020 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
KKKai-Qian Kam
Kai-Qian Kam
CYChee Fu Yung
Chee Fu Yung
MMMatthias Maiwald
Matthias Maiwald
CCChia Yin Chong
Chia Yin Chong
HSHan Yang Soong
Han Yang Soong
KTKoh Cheng Thoon
Koh Cheng Thoon
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected from at least 1 buccal specimen in 9 of 11 coronavirus disease 2019 (COVID-19)–infected children (81.8%). Viral loads in buccal specimens were substantially lower than those in nasopharyngeal specimens. Buccal swabs are not good as COVID-19 screening specimens in children.

4 July 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
CYChee Fu Yung
Chee Fu Yung
KKKai-Qian Kam
Kai-Qian Kam
CCChia Yin Chong
Chia Yin Chong
KNKaren Donceras Nadua
Karen Donceras Nadua
JLJiahui Li
Jiahui Li
KTKoh Cheng Thoon
Koh Cheng Thoon

1 August 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
RORina Yue Ling Ong
Rina Yue Ling Ong
SCSu-Wan Bianca Chan
Su-Wan Bianca Chan
SCSiu Jun Chew
Siu Jun Chew
WLWoei Kang Liew
Woei Kang Liew
KTKoh Cheng Thoon
Koh Cheng Thoon
NTNatalie Woon Hui Tan
Natalie Woon Hui Tan
Disseminated Bacillus Calmette-Guérin (BCG) disease (BCGosis) is a classical feature of children with primary immunodeficiency disorders (PIDs). A 15-year retrospective review was conducted in KK Women's and Children's Hospital in Singapore, from January 2003 to October 2017. Ten patients were identified, mostly male (60.0%). The median age at presentation of systemic signs and symptoms, was 4.0 (0.5 - 27.9) months. All the patients had underlying PIDs - five with Severe Combined Immunodeficiency (SCID), three with Mendelian Susceptibility to Mycobacterial Diseases (MSMD), one with Anhidrotic Ectodermal Dysplasia with Primary Immunodeficiency (EDA-ID), and one with STAT-1 gain-of function mutation. Definitive BCGosis was confirmed in all patients by identification of Mycobacterium bovis subsbp BCG from microbiological cultures. The susceptibility profiles of Mycobacterium bovis subsbp BCG are as follows: Rifampicin (88.8%), Isoniazid (44.47%), Ethambutol (100.0%), Streptomycin (100.0%), Kanamycin (100.0%), Ethionamide (25.0%), and Ofloxacin (100.0%). Four patients (40.0%) received a three-drug regimen. Five patients (50.0%) underwent haematopoietic stem cell transplant (HSCT), of which 3 (60%) have recovered. Overall mortality was 50.0%. Disseminated BCG disease (BCGosis) should prompt immunology evaluation to determine the diagnosis of the immune defect. A three-drug regimen is adequate for treatment if the patient undergoes early HSCT.